Kezar Life Sciences recently summarized its Q1 2019 activities. Essentially a pre-revenue, publicly traded biotech venture based in South San Francisco, CA, as of this writing their share price is $20.27 for a market capitalization of $387.55 million. Based on...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
